FOLLOW-UP PROCESS  

 

MULTIYEAR WORKPLAN 2019-2023

INTERSESSIONAL MEETINGS | RECONVENED SESSION | SPECIAL EVENTS | BRIEFINGS

  INTERSESSIONAL MEETINGS

  2020

 3rd ISM 19-21 October 2020

63rd CND 3rd INTERSESSIONAL MEETING 19-21 October 2020

Background note  

Day 1: 19 October 2020 || 2019 Ministerial Declaration challenges:
a) drug treatment and health services continue to fall short of meeting needs and deaths related to drug use have increased;

b) the rate of transmission of HIV, the hepatitis C virus and other blood-borne diseases associated with drug use, including injecting drug use in some countries, remains high;

UNODC introduction

Ms. Angela Me, Chief, UNODC Research and Trend Analysis Branch
Ms. Chloe CARPENTIER, Chief, UNODC Drug Research Section
Ms. Giovanna CAMPELLO, UNODC Prevention, Treatment and Rehabilitation Section
Ms. Fariba SOLTANI, Chief, UNODC HIV/AIDS Section & Global Coordinator for HIV/AIDS

Panel

Mr. Troy Jack Thevathasan, Deputy Director (Correctional Rehabilitation Services), Singapore Prison Service
Mr. Christopher M. Jones, PharmD, DrPH, MPH; CAPT, US Public Health Service; Deputy Director’ National Center for Injury Prevention and Control; Centers for Disease; Control and Prevention
Mr. Evgeny Bryun, Head of the Moscow Research and Practice Centre for Drug Addiction, Russian Federation
Dr. Tlaleng MOFOKENG (Ms.), UN Special Rapporteur on the right of everyone to the enjoyment of the highest attainable standard of health
Vladimir Poznyak, Coordinator, Coordinator, Alcohol, Drugs and Addictive Behaviours, [video message]|
Prof. Jallal Toufiq, Board Member, International Narcotics Control Board
Annette Verster, Technical Officer, Global HIV, Hepatitis and Sexually Transmitted Infections Programmes
Dr. Zukiswa ZINGELA, Board Member, International Narcotics Control Boar
Mr Ninan Varughese, Director a.i. of the Joint United Nations Programme on HIV and AIDS (UNAIDS) New York Office
Ms Jane Mounteney, Head of the Public Health Unit, European Monitoring Centre for Drugs and Drug Addiction
Mr. Phaedon KALOTERAKIS, World Federation for Therapeutic Communities, Greece
Ms. Colleen DANIELS, Harm Reduction International, United Kingdom, [statement]

Thematic debate

Ms. Giovanna CAMPELLO, UNODC Prevention, Treatment and Rehabilitation Section
Mr. Zaved Mahmood, Human Rights and Policy Advisor, Office of the High Commissioner for Human Rights
Dr. Massimo Barra, Vice-President IFCR
Ms. Stacey DOORLY-JONES, STAND – Social Transformation Action Defined, South Africa
Mr. Sharif MOHR, Drug Free America Foundation, United States, [video message]
Ms. Kathleen GANNON, Karim Khan Afridi Welfare Foundation, Pakistan, [video message]
Mr. Stelio CRAVEIRINHA, Mozambican Network of People who Use Drugs, Mozambique, [video message]
Ms. Laurene COLLARD, Civil Society Forum on Drugs, European Union, [video message]
Ms. Maria Angélica DE CASTRO COMIS, Centro de Convivência É de Lei, Brazil, [video message]
Statement by the Netherlands
Statement by the European Union
Statement by United States of America

Day 2: 20 October 2020 || 2019 Ministerial Declaration challenge: The adverse health consequences of and risks associated with new psychoactive substances have reached alarming levels

UNODC Introduction

Ms. Angela Me, Chief, UNODC Research and Trend Analysis Branch
Mr. Justice Tettey, Chief, UNODC Laboratory and Scientific Section

Panel

Dr. Owen Bowden-Jones, Chair of the UK Advisory Council on the Misuse of Drugs, O'Malley Kieran (Home Office Science)
Ms. Amrita DEVI, Director for Strengthening Community Based Rehabilitation Institutions, the Indonesian National Narcotics Board
Dr. Gady Zabicky Sirot, Comisionado Nacional contra las Adicciones de la Secretaría de Salud, Mexico, (National Commissioner Against Addictions of the Ministry of Health, Mexico
H.E. Ambassador David JOHNSON, Board Member, International Narcotics Control Board
Dilkushi Poovendran, Technical Officer, Expert Committee on Drug Dependence
H.E. Mr. Adam NAMM, Executive Secretary of the Inter-American Drug Abuse Control Commission (CICAD) of the Organization of American States (OAS)
Mr. Shane VARCOE, Dalgarno Institute, Australia, [video message]

Thematic debate

Mr. Wei HAO, Professor of Psychiatry, Second Xiangya Hospital, Central South University
Dr. Antonio Pascale, Director del Servicio de Toxicología y Uso Problemático de Drogas del Ministerio del Interior (Director of the Toxicology and Problematic Drug Use Service of the Ministry of the Interior)
Stefanie Caroline Schmatz, Associate Drug Control and Crime Prevention Officer, UNODC Laboratory and Scientific Section
Giovanna CAMPELLO, UNODC Prevention, Treatment and Rehabilitation Section
Monica Ciupagea, Expert, HIV/AIDS Section United Nations Office on Drugs and Crime
Ms. Eliza Kurcevič, Eurasian Harm Reduction Association (EHRA), Lithuania
Prof. Dr. Munir MOOSA, Global Forum for Teachers Educators, Pakistan
Ms. Nazlee MAGHSOUDI, Centre on Drug Policy Evaluation (CDPE), Canada
Mr. Mauro Adrián DÍAZ MORENO, Corporación Acción Técnica Social, Colombia, [video message]
Statement by the European Union
Statement by United States of America

Day 3: 21 October 2020 || 2019 Ministerial Declaration challenge: The availability of internationally controlled substances for medical and scientific purposes, including for the relief of pain and palliative care, remains low to non-existent in many parts of the world

UNODC Introduction

Ms. Chloé CARPENTIER, Chief, UNODC Drug Research Section
Ms. Elizabeth MATTFELD, UNODC Prevention, Treatment and Rehabilitation Unit, Drug Prevention and Health Branch

Panel

Dr. Musa UMAR, Director, (Narcotics and Controlled Substances), National Agency for Food, Drug Administration and Control (NAFDAC)
Mr. Atul AMBEKAR, M.D. Professor, National Drug Dependence Treatment Centre and Department of Psychiatry, All India Institute of Medical Sciences, New Delhi, India
Dr. Tammam Aloudat, Deputy Executive Director, Médecins Sans Frontières (MSF) Access Campaign
Dra. Adriana Templos, Jefa de División de Cuidados Paliativos del Hospital General Dr. Manuel Gea González (Head of the Palliative Care Division of the General Hospital Dr. Manuel Gea González)
Dr. Galina KORCHAGINA, Board Member, International Narcotics Control Board, Bulgaria
Gilles Forte, Coordinator, Access to Medicines and Health Products
Mr Alfredo POLO, Radiation Oncologist, IAEA Applied Radiation Biology and Radiotherapy Section
Ms. Marta Ximena León, Universidad de La Sabana, Colombia, [video message]

Thematic debate

Ms. Raffaella RAVINETTO, Institute of Tropical Medicine, Antwerp, Belgium
Stefanie Caroline Schmatz
Prof. David Nutt, Drug Science, United Kingdom
Ms. Diana NEVZOROVA, Hospice Care Professionals Association, Russian Federation, [video message]
Mr. Bishnu Fueal SHARMA, Recovering Nepal, National Federation of PUD and Drug services Organizations, Nepal, [video message]
Mr. Mark Donald BIKOSA MWES, Palliative Care Association of Uganda (PCAU), Uganda, [video message]
Dr. Katherine Pettus, Advocacy Officer, the International Association for Hospice and Palliative Care (IAHPC) & Ms. Kate Reed, Advocacy Focal Point IAHPC, National Clinical Advisor of Palliative Care Australia (PCA) (written submission)
David Oliver, The European Association for Palliative Care, PhD, FRCP, FCRGP, FEAN, Honorary Professor University of Kent, Canterbury, UK, Retired Consultant in Palliative Medicine at Wisdom Hospice, Rochester, UK, Member of European Union Civil Society Forum on Drugs (written submission)
Lauren Deluca, the Founding President and Executive Director of Chronic Illness Advocacy & Awareness Group (CIAAG) (written submission)
Statement by the European Union
Statement by United States of America

 

   2019

   6th ISM 16-18 October 2019

4th ISM 24 June 2019

62nd CND 6th INTERSESSIONAL MEETING 16-18 October 2019
Agenda | Background note | Photos | Webcast  

Day 1: 16 October 2019 || 2019 Ministerial Declaration challenge: both the range of drugs and drugs markets are expanding and diversifying

Ms. Angela Me, Chief, UNODC Research and Trend Analysis Branch

Panel
Mr. Federico Manotti, Public Prosecutor at the Court of Genoa, Italy
Ms. Mariana Souto Zabaleta, Instituto Latinoamericano de Seguridad y Democracia, Argentina

Thematic debate
Ms. Chloé Carpentier , UNODC Research and Trend Analysis Branch
Ms. Teodora Groshkova, Markets, Crime and Supply Reduction Risks to Public Safety and Security Unit
H.E. Ambassador Adam Namm, Executive Secretary, Inter-American Drug Abuse Control Commission (CICAD) [video message]
Mr. Inshik Sim, UNODC- Regional Office for Southeast Asia and the Pacific [video message]
Mr. Amado Philip de Andrés, Regional Representative, UNODC, Regional Office for Eastern Africa [video message]
Ms. Ashita Mittal, Regional Representative, UNODC Regional Office for Central Asia [video message]
Mr. Martin Raithelhuber, UNODC Laboratory and Scientific Section
Mr. Gilberto Gerra, Chief, UNODC Drug Prevention and Health Branch
Simone Haysom, Global Initiative Against Transnational Organized Crime, Austria
Mehmet Utku Öztürk, Turkish Green Crescent, Turkey [video message]
Núria Calzada Álvarez, Asociación Bienestar y Desarrollo (ABD), Spain [video message]

Day 2: 17 October 2019 ||  2019 Ministerial Declaration challenge: the abuse, illicit cultivation and production and manufacture of narcotic drugs and psychotropic substances, as well as the illicit trafficking in those substances and in precursors, have reached record levels and that the illicit demand for and the domestic diversion of precursor chemicals are on the rise
Ms. Angela Me, Chief, UNODC Research and Trend Analysis Branch

Panel
Mr. Sunday Joseph Nnona, Director of Prosecution and Legal Matters at the National Drug Law Enforcement Agency, Nigeria
Mr. Rajesh Nandan Srivastava, Deputy Director General (Operations), Narcotics Control Bureau, India
Mr. Juan Francisco Espinosa Palacios, Deputy Minister of Criminal Policy and Restorative Justice of the Ministry of Justice and Law, Colombia
Ms. Sofia Krauss, GIZ on behalf of Federal Ministry for Economic Cooperation and Development, Germany
Mr. Pedro Arenas García, Colombia, Corporación Viso Mutop-Observatorio de cultivos y cultivadores

Thematic debate
Ms. Anubha Sood, UNODC Country Office in Afghanistan [video message]
H.E. Khojesta Fana Ebrahimkhel, Ambassador of Afghanistan [video]
Mr. Erlend Falch, UNODC Country Office in Laos [video message]
Mr. Ketil Ottersen, UNODC Container Control Programme
Mr. Neil Walsh, UNODC Cybercrime and Anti-Money Laundering Section
Mr. Conor Crean, UNODC Laboratory and Scientific Section
Mr. Rossen Popov, International Narcotics Control Board
Mr. Gilberto Gerra, Chief, Drug Prevention & Health Branch
Ms. Elizabeth Saenz, UNODC Prevention, Treatment and Rehabilitation Section
Ms. Fariba Soltani, UNODC HIV/AIDS Section
Ms. Peggy Chukwuemeka, Parent-Child Intervention Centre, Nigeria
Mr. Bernice Auma Apondi, Voices of Community Action and Leadership, Kenya [video message]
Mr. Sai Lone, Myanmar Opium Farmers' Forum, Myanmar [video message]

Day 3: 18 October 2019 || 2019 Ministerial Declaration challenge: Synthetic opioids and the non-medical use of prescription drugs pose increasing risks to public health and safety, as well as scientific, legal and regulatory challenges, including with regard to the scheduling of substances
Ms. Angela Me, Chief, UNODC Research and Trend Analysis Branch

Panel
Mr. Sunday Joseph Nnona, Director of Prosecution and Legal Matters at the National Drug Law Enforcement Agency, Nigeria
Ms. D.P.P Weerasinghe, Assistant Director of Scientific Research, National Dangerous Drugs Control Board, Sri Lanka
Ms. Anna-Liisa Pääsukene, Adviser at the Public Health Department in the Estonian Ministry of Social Affairs [video message]
Mr. Stephen McGlynn, Minister Counsellor, Home Affairs, Permanent Mission of Australia to the United Nations in Geneva
Ms. Heloísa Broggiato Matter, International Association for Hospice and Palliative Care, on Overcoming the opioid crises and hitting SDG Targets - Opioids

Thematic debate
Mr. Evgeny Bruyn, Ministry of Health of the Russian Federation
Ms. Asma Fakhri, UNODC Laboratory and Scientific Section
Mr. Conor Crean, UNODC Laboratory and Scientific Section
Ms Dilkushi Poovendran, Division of Medicines and Health Products, WHO
Ms. Barbara Remberg, International Narcotics Control Board
Mr. Richard Sheehan, Universal Postal Union
Mr. Cristian Herrera, Organization for Economic Cooperation and Development
Ms. Elizabeth Saenz, UNODC Prevention, Treatment and Rehabilitation Section
Ms. Elizabeth Mattfeld, UNODC Prevention, Treatment and Rehabilitation Section
Mr. Stefano Berterame, International Narcotics Control Board
Ms. Lauren Deluca, Chronic Illness Advocacy & Awareness Group, USA [video message]
Mr. Chamrid Losdi Egnonna'm Kpadonou, West Africa Drug Policy Network / West Africa Civil Society Institute, Ghana [video message]
Ms. Gretchen Burns Bergman, A New PATH, United States of America [video message]
Mr. Kayode Adedoye, Society for Development & Community Empowerment, Nigeria

  62nd CND 4th INTERSESSIONAL MEETING 24 JUNE 2019
Agenda | Photos

    RECONVENED SESSION
Vienna, 12-13 December 2019
Documentation | Journals | Photos

SPECIAL EVENTS

Special Event of the CND, Commemoration of the United Nations International Day against Drug Abuse and Illicit Trafficking and Launch of the 2019 World Drug Report, 10 a.m., 26 June, Boardroom C, VIC, Vienna

 

UNODC introduction

Ms. Angela Me, Chief, UNODC Research and Trend Analysis Branch

Ms. Chloe CARPENTIER, Chief, UNODC Drug Research Section

Ms. Giovanna CAMPELLO, UNODC Prevention, Treatment and Rehabilitation Section

Ms. Fariba SOLTANI, Chief, UNODC HIV/AIDS Section & Global Coordinator for HIV/AIDS

 

    Copyright©2021 UNODC, All Rights Reserved, Legal Notice